A 52-year-old man with recurrent major depressive disorder presents with passive suicidal ideation and hopelessness. He has failed trials of sertraline and escitalopram. Which agent is the preferred choice for suicide risk reduction in treatment-resistant depression?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.